We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Edan Instruments

EDAN Instruments manufactures and distributes diagnostic medical equipments in the areas of obstetrics & gynecology, ... read more Featured Products: More products

Download Mobile App





EDAN Takes its Solutions up a Notch at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022
Print article
Image: EDAN at MEDICA 2022 with its latest innovations (Photo courtesy of EDAN)
Image: EDAN at MEDICA 2022 with its latest innovations (Photo courtesy of EDAN)

EDAN Instruments, Inc. (Shenzhen, China) is demonstrating its range of latest innovations at MEDICA, the premiere global medical trade show being held at Dusseldorf, Germany, from Nov. 14 to 17, 2022. The company is presenting five new products to more than 120,000 visitors from over 150 countries at the world’s largest trade fair for the medical sector.

For the laboratory sector, EDAN is showcasing its combined range of POCT and IVD innovations at its booth this year, including the ClariLight CL30, its first molecular diagnostics solution. The ClariLight CL30 is a new point of care (POC) molecular diagnostics analysis system based on Loop-Mediated Isothermal Amplification (LAMP) that provides on-the-spot results and empowers physicians for early infectious disease diagnostics, thanks to its agility, speed and flexibility. ClariLight CL30 is designed to offer effective solutions for infectious disease diagnostics by reducing the window period. Unlike PCR-based methods (generally non-portable, laboratory setting, time-consuming), CL30 produces molecular results as quick as 15 minutes, while multi-parameters cartridges and the extraction-free procedure allow massive and rapid molecular tests feasible.

At MEDICA 2022, EDAN is also showcasing iX Series, its next-generation patient monitor that comes with a widescreen design and optimized workflow. Its innovative non-invasive technologies and selective clinical tools contribute to more efficient patient monitoring. Visitors to EDAN’s booth at MEDICA 2022 can experience two ready-to-launch products from the company, including the fully-automated electrocardiograph SE-1201 Pro, and the Holter ECG & ABP 2-in-1 wearables SA-20, tailored for the diagnosis of cardiogenic hypertension. In the obstetrics & gynecology area, EDAN is presenting its portable biofeedback and stimulation system, PA4 Pro, which allows physiotherapists to deliver pelvic floor muscular assessment and treatment flexibly in any scenario. For the first time, EDAN is also exhibiting the upgraded version of Acclarix LX9 alongside its technologically upgraded transducers.

"The highlight is our first molecular diagnostics solution, ClariLight CL30. We are glad to see that most clients are attracted by its rapid results as quick as 15 minutes," said Bo Wang, IVD & POCT Marketing Manager at EDAN.

"A rolling stone gathers no moss. Our breakthrough is visible," said Alex You, Senior Director of EDAN Global Marketing & Strategic Operations, after having a dialogue on EDAN's global development plan with Mr. Wolfram Nikolaus Diener, President & CEO of Messe Dusseldorf GmbH. "And we will go further with a steady stream to advance in our journey towards improving human living conditions."

Related Links:
EDAN Instruments, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Pathology

view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more

Industry

view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.